Live feed21:30:08·139dINSIDERFilingvia QuantisnowChief Research Officer Rote William E. was granted 20,090 shares and sold $409,100 worth of shares (12,446 units at $32.87), increasing direct ownership by 8% to 109,087 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TVTX· Travere Therapeutics Inc.Health CareOriginal source
